Parkinson's disease, Daniel Barenboim
Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 ...
The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
20hon MSN
A drug for treating diabetes similar to popular weight-loss medicines such as Ozempic did not show any benefits for people ...
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
AI-powered blood test detects Parkinson's disease years before symptoms appear, revolutionizing early diagnosis and treatment ...
11h
Hosted on MSNOzzy Osbourne's Heartbreaking Health Update: Inside the Rocker's Debilitating Struggle With Parkinson's DiseaseWhat is Ozzy Osbourne's health situation? Ozzy lives with Parkinson's disease, and has had numerous surgeries over the ...
16hon MSN
Sharon Osbourne gave an update on how Parkinson’s disease has impacted husband Ozzy Osbourne’s legs as the musician prepares ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results